E. Donnall Thomas Lecture and Prize Recipients
The following individuals received the E. Donnall Thomas Lecture and Prize. This lectureship was created in 1992 and named after the late Nobel Prize laureate and past society president E. Donnall Thomas. The E. Donnall Thomas Lecture and Prize is intended to recognize pioneering research achievements in hematology that have represented a paradigm shift or significant discovery in the field.
Learn more about the E. Donnall Thomas Lecture and Prize.
Year | Recipient | Information | Topic |
---|---|---|---|
2025 | Nancy Speck, PhD | Core Binding Factor in Blood Cell Formation and Leukemia | |
2024 | Sean J. Morrison, PhD | Hematopoietic Stem Cell Maintenance | |
2023 | Katy Rezvani | Natural Killer Cells: A New Frontier for Cancer Immunotherapy | |
2022 | Bruce Blazar | The Long and Winding Road to Clinically Effective Graft-versus-Host Disease (GVHD) Therapeutics | |
2021 | Connie Westhoff | Rh and Transfusion in the Era of Genomics | |
2020 | Toshio Suda | Quiescence and Cell Metabolism in Hematopoietic Stem Cells | |
2019 | Philip Greenberg | The long road to develop adoptive therapy with T cells that can effectively target AML and other malignancies | |
2018 | Connie J. Eaves | Blood Stem Cells: A Simple Concept, But a Complex Reality | |
2017 | James R. Downing | The Molecular Pathology of Pediatric Acute Leukemia | |
2016 | David Scadden |
|
Bone Marrow: Structure and Function of the Blood Cell Foundry |
2015 | Barbara Furie and Bruce Furie | Thiol Isomerases as Potential Regulators Controlling the Initiation of Thrombus Formation | |
2014 | Tomas Ganz | Iron, Erythropoiesis, and Host Defense: A Ménage à Trois | |
2013 | Katherine A. High | Sailing to Ithaka: Gene Therapy’s Odyssey from Investigational Agent to Therapeutic Product | |
2012 | Timothy J. Ley | The AML Genome |